ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, providing promising developments across several clinical and industrial applications. With its structural similarity to By natural means derived human serum albumin, OsrHSA provides a safer, additional reliable substitute for therape